Wikipedia -WSS

Wikipedia

author：entertainment 2025-10-01 23:06:44 - browse：18

Intellia Therapeutics said Sunday that the first 10 patients to receive a CRISPR-based treatment for hereditary angioedema, a genetic disease, saw their swelling attacks — the condition’s hallmark symptom — virtually eliminated for an average of 20 months and counting.

The attacks were reduced by an average of 98%. One patient has remained attack-free for 26 months. Two patients who suffered particularly frequent attacks, experiencing 14 and 16.8 per month, respectively, have now gone more than 20 months since their last attack.

No patient has had an attack in the last 11 months of follow-up, according to the data presented at the European Academy of Allergy and Clinical Immunology Congress. All side effects were either grade 1 or 2 on a 5-grade scale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Mike Pence clashes with Tucker Carlson in Iowa

WSS

Pig kidney works a record two months in donated body

Care demand spikes challenge UnitedHealth’s provider arm

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Hospitals consider fixing cancer drug shortages on their own

How to make the FDA’s new prescription one

Eli Lilly to acquire Versanis in heated race for weight loss drugs

leisure time

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

Hollywood unions extend contract negotiations for actors

Europe sees delivery challenges ahead on Alzheimer's therapies

Novavax promises a turnaround & Lilly roils the obesity market

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Psychedelics group wrestles with new pharma identity

Generate Biomedicines machine learning biotech raises $273M

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Acelyrin, a rare IPO success, stumbles in its first big test

Continuity nursing helped my family in our darkest PICU moments

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

focus

Celiac disease study examines precisely how gluten triggers injury

IRA could hurt research into orphan drugs for rare diseases

The new HIV moral panic

Grail faces three suits alleging harassment, retaliation

Walmart eyes Medicare Advantage provider ChenMed

Telehealth for opioid use disorder is lifesaving

knowledge

entertainment

explore

Wikipedia